Junhao Lin

1.1k total citations
30 papers, 831 citations indexed

About

Junhao Lin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junhao Lin has authored 30 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junhao Lin's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and RNA and protein synthesis mechanisms (5 papers). Junhao Lin is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and RNA and protein synthesis mechanisms (5 papers). Junhao Lin collaborates with scholars based in China, United States and France. Junhao Lin's co-authors include Yuchen Liu, Yonghao Zhan, Weiren Huang, Chengle Zhuang, Zhicong Chen, Anbang He, Jianfa Li, Zhiming Cai, Mingwei Chen and Guoping Zhao and has published in prestigious journals such as Cell, Nature Methods and Journal of Hazardous Materials.

In The Last Decade

Junhao Lin

27 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhao Lin China 15 676 513 60 55 52 30 831
Irene K. Guttilla Reed United States 10 720 1.1× 577 1.1× 191 3.2× 30 0.5× 36 0.7× 13 902
Adriana Soto-Guzmán Mexico 9 223 0.3× 162 0.3× 103 1.7× 40 0.7× 26 0.5× 22 427
Hui Fan China 13 483 0.7× 229 0.4× 86 1.4× 15 0.3× 45 0.9× 23 648
Xiwang Zheng China 12 495 0.7× 289 0.6× 95 1.6× 13 0.2× 53 1.0× 23 632
Rossella Loria Italy 10 271 0.4× 161 0.3× 85 1.4× 22 0.4× 56 1.1× 14 449
Yuting Kuang China 10 241 0.4× 187 0.4× 39 0.7× 28 0.5× 35 0.7× 20 386

Countries citing papers authored by Junhao Lin

Since Specialization
Citations

This map shows the geographic impact of Junhao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhao Lin more than expected).

Fields of papers citing papers by Junhao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhao Lin. The network helps show where Junhao Lin may publish in the future.

Co-authorship network of co-authors of Junhao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Junhao Lin. A scholar is included among the top collaborators of Junhao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhao Lin. Junhao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Junhao, et al.. (2026). Extracellular GPX4 impairs antitumor immunity via dendritic ZP3 receptors. Cell. 189(4). 1056–1073.e24.
2.
Lin, Junhao, Yuchuan Jiang, Xinhui Liu, et al.. (2025). Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway. Frontiers in Oncology. 14. 1517226–1517226.
3.
Wang, Chao, Junhao Lin, Jiewei Deng, et al.. (2025). 6PPD and 6PPDQ exposure promote the proliferation and migration of non-small cell lung cancer cells through PTEN dysfunction and ARG2-mediated metabolic reprogramming. Journal of Hazardous Materials. 495. 139088–139088. 2 indexed citations
4.
Lin, Junhao, Fangquan Chen, Hu Tang, et al.. (2025). CDC26 facilitates ferroptosis through SLC7A11 degradation and cell cycle arrest. Clinical and Experimental Medicine. 26(1). 11–11.
5.
Chen, Fangquan, Hu Tang, Junhao Lin, et al.. (2024). Macropinocytosis inhibits alkaliptosis in pancreatic cancer cells through fatty acid uptake. Carcinogenesis. 45(12). 953–964. 6 indexed citations
6.
Chen, Fangquan, Junhao Lin, Rui Kang, Daolin Tang, & Jiao Liu. (2024). Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition. Molecular Carcinogenesis. 63(8). 1515–1527. 8 indexed citations
7.
Chen, Fangquan, Hu Tang, Junhao Lin, et al.. (2024). Targeting paraptosis in cancer: opportunities and challenges. Cancer Gene Therapy. 31(3). 349–363. 17 indexed citations
8.
Chen, Fangquan, et al.. (2023). Cholesterol Metabolism in Cancer and Cell Death. Antioxidants and Redox Signaling. 39(1-3). 102–140. 25 indexed citations
9.
Li, Chunlin, Zhi Chen, Ximing Li, et al.. (2022). Effect of AKT silence on malignant biological behavior of renal cell carcinoma cells. BMC Urology. 22(1). 129–129. 1 indexed citations
10.
Wang, Juntao, et al.. (2020). Application of external fixator traction in the treatment of syndactyly. Journal of Orthopaedic Translation. 25. 39–42. 6 indexed citations
11.
Lin, Junhao, Yonghao Zhan, Yuchen Liu, et al.. (2017). Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer. Oncotarget. 8(15). 24202–24212. 33 indexed citations
12.
Liu, Yuchen, Yonghao Zhan, Zhicong Chen, et al.. (2016). Directing cellular information flow via CRISPR signal conductors. Nature Methods. 13(11). 938–944. 148 indexed citations
13.
He, Anbang, Yuchen Liu, Zhicong Chen, et al.. (2016). Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 125–125. 53 indexed citations
14.
Zhan, Yonghao, Junhao Lin, Yuchen Liu, et al.. (2016). Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 83–83. 67 indexed citations
15.
Chen, Mingwei, Chengle Zhuang, Yuchen Liu, et al.. (2016). Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Cancer Letters. 376(1). 155–164. 80 indexed citations
16.
Li, Jianfa, Chengle Zhuang, Yuchen Liu, et al.. (2016). Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 99–99. 61 indexed citations
17.
Liu, Yuchen, Zhicong Chen, Anbang He, et al.. (2016). Targeting cellular mRNAs translation by CRISPR-Cas9. Scientific Reports. 6(1). 29652–29652. 23 indexed citations
18.
Zhan, Yonghao, Yuchen Liu, Chaoliang Wang, et al.. (2016). Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Oncotarget. 7(13). 16038–16048. 38 indexed citations
19.
Zhan, Yonghao, Yuchen Liu, Junhao Lin, et al.. (2015). Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637. Scientific Reports. 5(1). 16177–16177. 15 indexed citations
20.
Lin, Junhao, Yuchen Liu, Yonghao Zhan, et al.. (2015). Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells. Tumor Biology. 37(3). 3115–3121. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026